Paul Elliot Mann Sells 83,758 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

Key Points

• CEO Paul Mann sold 83,758 ASP Isotopes shares at an average $3.91 for $327,494, reducing his stake by 0.87%; the sale covered tax-withholding obligations from vested equity awards. He also sold 83,759 shares at $4.10 on September 4.
• ASP Isotopes shares rose 7.7% to $4.20, despite the company reporting a quarterly EPS loss of $0.28 that missed estimates, alongside $5.12 million in revenue that exceeded forecasts.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and a $13 average price target; institutional investors own 16.8% of the company, including new positions from BlackRock and other firms.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) CEO Paul Mann sold 83,758 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $3.91, for a total transaction of $327,493.78. Following the completion of the transaction, the chief executive officer owned 9,496,087 shares in the company, valued at approximately $37,129,700.17. The trade was a 0.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Paul Elliot Mann also recently made the following trade(s):

• On Friday, September 4th, Paul Mann sold 83,759 shares of ASP Isotopes stock. The shares were sold at an average price of $4.10, for a total value of $343,411.90.

ASP Isotopes Stock Up 7.7%

Shares of ASP Isotopes stock traded up $0.30 during trading on Friday, reaching $4.20. 3,831,544 shares of the company traded hands, compared to its average volume of 2,936,087. The firm has a market capitalization of $643.90 million, a PE ratio of -3.18 and a beta of 3.59. ASP Isotopes Inc. has a 1-year low of $3.51 and a 1-year high of $14.49. The company has a 50 day moving average price of $4.37 and a 200-day moving average price of $5.20. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.11). The firm had revenue of $5.12 million during the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ASPI. Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Wall Street Zen raised shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a report on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $13.00.

Institutional Trading of ASP Isotopes

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new position in ASP Isotopes in the 2nd quarter valued at $57,331,000. HITE Hedge Asset Management LLC bought a new position in shares of ASP Isotopes in the fourth quarter worth $2,407,000. AWM Investment Company Inc. purchased a new stake in shares of ASP Isotopes in the second quarter worth $9,837,000. Encompass Capital Advisors LLC purchased a new stake in shares of ASP Isotopes in the first quarter worth $30,551,000. Finally, SBI Securities Co. Ltd. boosted its stake in ASP Isotopes by 196.2% during the fourth quarter. SBI Securities Co. Ltd. now owns 152,120 shares of the company's stock valued at $814,000 after buying an additional 100,769 shares during the period. Institutional investors own 16.80% of the company's stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source